From Regulation to Innovation: Lilly’s Strategic Evolution in the Wake of IVDR
- The evolution of the Dx team in a pharma company
- How IVDR prompted deeper integration between Regulatory Affairs, Quality, Clinical, and Laboratory teams
- Which changes to the IVDR could streamline clinical trials in the EU